Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer

Table 1

Clinical biochemical and pathology finding in patients with severe primary hyperparathyroidism.

Parameter	N=59
Age (year)	54 ± 15
Female gender	46 (78%)
Serum Calcium (mg/dl)	11.4 (11-12-1)
Serum Phosphorus (mg/dl)	2.6 (2.2-2.8)
PTHi (pg/ml)	147 (117-243)
Vitamin D (ng/ml)	14.9± 5.36
Urinary calcium (mg/24-hour)	318 (210-373)
Creatinine clearance (ml/min)	79.4± 27.4
Hypertensive crisis	5 (8.5%)
Renal stone	28 (47%)
Osteoporosis	29 (49%)
Pancreatitis	2 (3.4%)
Hypertension	33 (56%)
Prediabetes	24 (41%)
Diabetes	6 (10%)
Histopathologic finding (%)
Adenoma	51 (86%)
Hyperplasia	8 (14%)